About Index Trending news
Analyze
Pricing
BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

Work at BrainStorm Cell Therapeutics? Add yourself to this profile

BrainStorm Cell Therapeutics

Biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD.
Edit Profile
More info

Elsewhere

Contributors to this profile

Also headquartered in New York

Verizon Verizon IBM IBM HBO HBO Kickstarter Kickstarter Wired Wired AOL AOL Tumblr Tumblr Goldman Sachs Goldman Sachs Time Warner Time Warner BuzzFeed BuzzFeed

Companies in the same industry

Hookipa Biotech Hookipa Biotech Theranica Theranica Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Arcturus Therapeutics Arcturus Therapeutics Mirna Therapeutics, Inc. Mirna Therapeutics, Inc. Cidara Therapeutics Cidara Therapeutics Lysosomal Therapeutics Lysosomal Therapeutics Biscayne NeuroTherapeutics Biscayne NeuroTherapeutics Adnexus Adnexus Insulete Inc. Insulete Inc.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
Add round
21 Jul 2017
$16,000,000
Grant
California Institute for Regenerative Medicine

Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

prnewswire
13 Jun 2017
$2,100,000
Grant
Israel Innovation Authority

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy

Drug Delivery Business
24 Jul 2014
$5,000,000
Grant
13 Jun 2014
$10,500,000
Post-IPO equity
09 May 2014
$1,632,689
Venture capital